DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY — Stella

Home/Cancer of the Breast/

View on ClinicalTrials.gov

Recruiting

Back to Cancer of the Breast trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

Yale University, New Haven, Connecticut

The Ohio State University, Columbus, Ohio

Key details

Phase

Safety & dosing

Sponsor

Ohio State University Comprehensive Cancer Center

Collaborators

National Institute on Aging (NIA), Yale University

Enrollment target

~140 participants

Started

February 2025

Primary completion

August 2029

Age range

40 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.